SCHEMBL6557583

SCHEMBL6557583

NC(=O)[C@H](C(=O)NC1CC(O)C(O)C1)S(=O)(=O)Cc1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 1/20 0.37
SLC1A2 P43004 1/20 0.37
SLC1A1 P43005 1/20 0.37
F2 P00734 2/20 0.37
PRSS1 P07477 2/20 0.37
PRSS2 P07478 2/20 0.37
PRSS3 P35030 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
AGTR2 P50052 1/20 0.37
CA1 P00915 3/20 0.36
CA2 P00918 3/20 0.36
CA5A P35218 2/20 0.36
CA9 Q16790 2/20 0.36
CA12 O43570 1/20 0.36
CA4 P22748 1/20 0.36
CA6 P23280 1/20 0.36
CA7 P43166 1/20 0.36
CA13 Q8N1Q1 1/20 0.36
CA14 Q9ULX7 1/20 0.36
CA5B Q9Y2D0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6560207 0.86 GRM7 (0.37) SLC1A3SLC1A2SLC1A1F2PRSS1
SCHEMBL6559792 0.84 USP2 (0.39) SLC1A3SLC1A2SLC1A1F2PRSS1
SCHEMBL6557913 0.82 GBA1 (0.39) SLC1A3SLC1A2SLC1A1F2PRSS1
SCHEMBL5441936 0.78 XIAP (0.40) SLC1A3SLC1A2SLC1A1SMN1; SMN2AGTR2
SCHEMBL7551628 0.73 CTSS (0.49)
SCHEMBL6558896 0.69 CYP3A4 (0.37) SLC1A3SLC1A2SLC1A1F2PRSS1
SCHEMBL6557593 0.68 KEAP1 (0.41) MMP1MMP2MMP9MMP8MMP13
SCHEMBL6557623 0.67 KMT2A (0.38) SLC1A3SLC1A2SLC1A1F2PRSS1
SCHEMBL19358523 0.66 GBA1 (0.43) EPHX2
SCHEMBL8548058 0.66 ALDH1A1 (0.65) TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1436255-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS Aventis Pharmaceuticals, Inc. (US) 2004-07-14 EP disclosed
WO-2003024924-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2003-03-27 WO disclosed